|
General information
|
|
Sex (female/male)
|
36/45
|
22/22
|
0.552
|
|
Age, years
|
6.54 ± 3.03
|
7.61 ± 2.49
|
0.031
|
|
Weight, kg
|
20.4 (16.4, 28.9)
|
27.2 (20.0, 33.5)
|
0.002
|
|
Clinical presentation n (%)
|
|
Fever
|
81 (100%)
|
44 (100%)
|
1.00
|
|
Cough
|
75 (92.6%)
|
43 (97.7%)
|
0.891
|
|
Hypoxemia
|
6 (7.41%)
|
28 (63.6%)
|
0.000
|
|
respiratory failure
|
0
|
2 (4.55%)
|
0.041
|
|
Extra-pulmonary complications
|
18 (22.2%)
|
33 (75.0%)
|
0.007
|
|
Thromboembolism
|
2 (2.47%)
|
2 (4.55%)
|
0.613
|
|
total fever duration, days
|
11 (8, 13)
|
13 (11, 15)
|
0.000
|
|
preadmission fever duration, days
|
7 (5, 8)
|
6 (4, 7)
|
0.329
|
|
fever duration at the time of CS treatmenta, days
|
1.95 ± 1.91
|
5.45 ± 2.76
|
0.000
|
|
Length of stay, days
|
8 (7, 10)
|
13.5 (11.3, 16)
|
0.000
|
|
Management
|
|
Hormone dose, mg/kg/day
|
2 (1.5, 2)
|
10 (8.5, 10)
|
0.000
|
|
Gamma globulin, n (%)
|
9 (11.1%)
|
17 (38.6%)
|
0.000
|
|
Bronchoscopy, n (%)
|
57 (70.4%)
|
41 (93.2%)
|
0.000
|
|
Plastic bronchitis, n (%)
|
14 (17.3%)
|
29 (65.9%)
|
0.000
|
